Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: IEEE J Biomed Health Inform. 2021 Sep 3;25(9):3541–3553. doi: 10.1109/JBHI.2021.3064353

Table III.

Performance of all submissions for the LVQuan 2018 challenge on the training dataset with 145 subjects under the five-fold cross validation (CV) protocols. For each task, only the average performance is shown here and the best result is highlighted in boldface. Average MAE is shown for areas, dimensions and RWTs, and error rate is shown for cardiac phase. All the methods achieved performance better or close to the state-of-the-art DMTRL.

Methods Area (mm2) Dimension (mm) RWT (mm) Phase (%)
SG-based methods
ResUNet 62.3 0.79 0.68 6.72
ESUPNet 62 1.14 0.96 8
UNetMF 141.7 1.77 1.39 -
MMED-S 120 1.25 1.03 7.8
SegNetRFf - - - 10
CNTCVX 176 2.23 1.75 10.3
DR-based methods
LDAMT 156 2.03 1.38 8.1
MMED-R 158 2.08 1.51 9.4
HQNet* 197 2.57 1.51 9.8
CNN3DST 190 2.29 1.42 3.85
FNN2D3D 188 2.42 1.42 8.76
Combined methods
MMED-SR 142 1.94 1.42 8.6
EnCNNU 124 2.27 1.62 13.7
DenseUMT 173 2.44 1.37 7.8
DMTRL 180 2.51 1.39 8.2

45 subjects in the training set were used for test;

only Pearson correlation coefficients were report on the training set;

*

7-fold CV was used;

3-fold CV was used. For MMED, the results for all three modes were reported.